News For RDY From The Last 14 Days Check below for free stories on RDY the last two weeks.
There are 5 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 22, 2012
|
| 05:18 EDT |  | RDY |
|
|
May 21, 2012
|
| 05:30 EDT | | RDY |
| theflyonthewall.com: | Dr. Reddy’s nnounces launch of OTC Lansoprazole delayed-releas capsules | | Dr. Reddy’s Laboratories announced that it has launched over-the-counter, or OTC, Lansoprazole delayed-release capsules in the U.S. market on May 18, following Dr. Reddy’s ANDA approval by the U.S. FDA). Dr. Reddy’s will market the product under store brand labels in the U.S. market. The product is the bioequivalent version of Novartis Consumer Health’s Prevacid24 HR capsule which received Rx-to-OTC switch approval with 3 year exclusivity from the FDA on March 18, 2009. The Prevacid24 HR capsule market had brand sales of approximately $115M for the twelve months ending March 2012 according to SymphonyIRI InfoScan Reviews. Dr. Reddy’s Lansoprazole Capsule in 15 mg strength is available in 14, 28 and 42 count pack size. Prevacid24 HR is a registered trademark of Takeda Pharmaceuticals (TKPHF). :theflyonthewall.com |
|
|
May 18, 2012
|
| 05:35 EDT | | RDY |
| theflyonthewall.com: | Dr. Reddy's Labs announces the launch of Clopidogrel tablets, USP | | Dr. Reddy’s Laboratories announced that it has launched CLOPIDOGREL TABLETS, USP 75 mg & 300 mg, a bioequivalent generic version of PLAVIX, in the U.S. market on May 18. The ANDAs for Clopidogrel Tablets USP, 75 mg & 300 mg are approved by the U.S. FDA, or USFDA. Dr. Reddy’s Laboratories was among the first applicants to submit a substantially complete ANDA for Clopidogrel Tablets USP, 300 mg with a Paragraph IV certification, and was awarded 180 days of marketing exclusivity for this strength. The PLAVIX brand had U..S. sales of approximately $6.740B for the most recent twelve months ending March 2012 according to IMS Health. :theflyonthewall.com |
|
|
May 17, 2012
|
| 15:47 EDT | | RDY |
|
|
May 14, 2012
|
| 08:57 EDT |  | RDY |
| theflyonthewall.com: | Dr. Reddy's Labs upgraded to Overweight from Neutral at JPMorgan | | :theflyonthewall.com |
|
|
|
Subscribe for More Information